Serum inflammatory cell adhesion molecules predict malignant cerebral edema and clinical outcome early after

Rongguo Hu1, Duyi Zhang1, Zhen Hu2

  • 1Dept. of Neurology, Gongli Hospital, The Second Military Medical University, Shanghai 200135, PR China.

Abstract

Insights

Serum E-selectin levels measured 12 hours after mechanical thrombectomy (MT) can predict malignant cerebral edema (MCE) and improve outcomes in acute ischemic stroke (AIS) patients.

Area of Science:

  • Neurology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Malignant cerebral edema (MCE) is a life-threatening complication after mechanical thrombectomy (MT) for acute ischemic stroke (AIS).
  • Cell adhesion molecules (CAMs) and Kruppel-like transcription factor (KLF) 4 are involved in post-stroke inflammation, but their role in MCE prediction after MT is underexplored.

Purpose of the Study:

  • To investigate the association between serum levels of CAMs and KLF4 post-MT and the development of MCE in AIS patients.
  • To determine if these molecular markers can predict MCE and patient outcomes after MT.

Main Methods:

  • Retrospective analysis of AIS patients who underwent MT for large-vessel occlusion.
  • Measurement of serum E-selectin, ICAM-1, VCAM-1, and KLF4 levels at 12 hours post-MT.
  • Assessment of MCE via CT scans within 5 days and evaluation of 3-month outcomes.

Main Results:

  • 19.8% of patients developed MCE.
  • Elevated serum E-selectin and ICAM-1 levels were associated with MCE.
  • Serum E-selectin demonstrated significant predictive value for MCE (AUC=0.7).
  • E-selectin and ICAM-1 levels were independently associated with 3-month outcomes.

Conclusions:

  • Serum E-selectin is a promising early biomarker for predicting MCE after MT in AIS.
  • Elevated E-selectin and ICAM-1 levels are linked to poorer outcomes in AIS patients post-MT.